The Population Pharmacokinetics of Montelukast in Infants and Children

Shandong University

Status: Unknown

Conditions: Asthma

Treatments: Drug: Montelukast Chewable Tablet

Study type: Observational

Funder types: Other

Identifiers

NCT03238560

2016Montelukast001

Details and patient eligibility

About

The investigators' aim was to evaluate the population pharmacokinetics of montelukast in infants and children and define the appropriate dose in order to optimize Montelukast treatment in this vulnerable population.

Enrollment: 100 estimated patients

Sex: All

Ages: 1 month to 12 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients have been diagnosed with asthma; age range: 1 month to 12 years old; montelukast used as part of regular treatment.

Exclusion criteria

• expected survival time less than the treatment cycle; patients with other factors that researcher considers unsuitable for inclusion.